Positive Phase 3 Topline Results for Early Parkinson ' s Drug Positive Phase 3 Topline Results for Early Parkinson ' s Drug

The novel drug P2B001 is superior to its individual components of pramipexole or rasagiline for early Parkinson ' s disease ― with less daytime sleepiness, new topline results suggest.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news